Article

Neoadjuvant treatment using chemotherapy and targeted therapy in a patient with resectable lung adenocarcinoma harboring BRAF V600E-mutation

2024-03-05

Abstract excerpt

In recent years, there has been significant progress in the treatment of non-small cell lung cancer (NSCLC). Besides conventional chemotherapy, targeted therapy and immunotherapy have demonstrated considerable efficacy in treating advanced NSCLC patients in both first and second-line settings. However, neoadjuvant therapy, as a promising therapeutic approach, requires further evaluation of its efficacy. Although t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a7711202-323a-5aa4-a984-53c8678ca074
DOI: 10.21203/rs.3.rs-3995612/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Neoadjuvant treatment using chemotherapy and targeted therapy in a patient with resectable lung adenocarcinoma harboring BRAF V600E-mutationDOI 10.21203/rs.3.rs-3995612/v1Read

Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report.Semantic proximity Read

Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study.Semantic proximity Read

Current indications for surgery in patients with lung cancer after neoadjuvant targeted therapy: a systematic review.Semantic proximity Read

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients.Semantic proximity Read

[Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer].Semantic proximity Read

[Advances in neoadjuvant therapy for EGFR-mutant non-small cell lung cancer].Semantic proximity Read

[A randomized controlled study of erlotinib versus pemetrexed combined with cisplatin in neoadjuvant therapy of stage ⅢA EGFR-mutant lung adenocarcinoma].Semantic proximity Read

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC in Traditionally Unresectable PatientsSemantic proximity Read

Targeted therapy in BRAF-mutated lung adenocarcinoma.Semantic proximity Read

Feasibility and safety of EGFR-TKI neoadjuvant therapy for EGFR-mutated NSCLC: A meta-analysis.Semantic proximity Read

Efficacy and safety of neoadjuvant targeted therapy in non-small cell lung cancer: a systematic review and meta-analysis.Semantic proximity Read

Perioperative targeted therapy for oncogene-driven NSCLC.Semantic proximity Read